Clinical Trials Browser

Phase 2 × Urethral Neoplasms × Trastuzumab × Clear all

NCT00004856 2013-05-03

Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium

Phase 2 Terminated

Urinary Bladder Neoplasms, Urethral Neoplasms